-
ANTIBIOTIC USE AND EXPENDITURE IN TUNISIA: INSIGHTS FROM THE WHO AWARE CLASSIFICATION
Aug 11, 2026, 17:16 PM -
A MULTI-SCALE CLASSICAL AI FRAMEWORK FOR SYSTEM-LEVEL VALUE ASSESSMENT OF HEALTH TECHNOLOGY ADOPTION
Aug 11, 2026, 17:16 PM -
TOWARDS OPTIMIZED CAR-T CELL THERAPY MANAGEMENT: CURRENT OPERATIONAL AND REGULATORY CHALLENGES FROM A PROCESS PERSPECTIVE
Aug 11, 2026, 17:16 PM -
ECONOMIC VALUE OF PERSONALIZED LIFESTYLE INTERVENTIONS: MAPPING THE EVIDENCE
Aug 11, 2026, 17:16 PM -
REFILL INTERVALS AS MARKERS OF CALENDAR-TIME CYCLE TIMING IN CYCLIC ORAL ANTICANCER THERAPY: VALIDATION USING AN INTRAVENOUS CYCLE ANCHOR IN GASTRIC CANCER REAL-WORLD DATA
Aug 11, 2026, 17:16 PM -
A TABULAR FOUNDATION MODEL FOR OUTREACH TARGETING: PREDICTING SENIOR EMPLOYMENT PROGRAM WILLINGNESS AMONG OLDER NONPARTICIPANTS USING WELFARE SURVEY DATA
Aug 11, 2026, 17:16 PM -
EVALUATION OF MEDICINES FROM WHO MODEL LIST OF ESSENTIAL MEDICINES WITHIN NATIONAL HTA PROCEDURE IN UKRAINE: FINDINGS AND IMPLICATIONS
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS ANALYSIS OF LIPOSOMAL IRINOTECAN IN COMBINATION WITH OXALIPLATIN, 5-FLUOROURACIL AND LEUCOVORIN (NALIRIFOX) FOR THE FIRST-LINE TREATMENT OF ADULT PATIENTS WITH METASTATIC ADENOCARCINOMA OF THE PANCREAS IN GREECE
Aug 11, 2026, 17:16 PM -
MORTALITY, DISEASE BURDEN AND HEALTHCARE RESOURCE USE IN PATIENTS WITH TRANSTHYRETIN AMYLOIDOSIS WITH CARDIAC INVOLVEMENT IN SPAIN: RESULTS FROM THE OVERTTURE GLOBAL STUDY
Aug 11, 2026, 17:16 PM -
TREAT NOW, PROVE LATER? EU5 PAYER PERSPECTIVES ON PRE-SYMPTOMATIC GENE THERAPY FOR HUNTINGTON'S DISEASE
Aug 11, 2026, 17:16 PM -
MIND THE GAP: INEQUITIES IN MARKET ACCESS TIMELINES ACROSS EUROPE
Aug 11, 2026, 17:16 PM -
HEALTHCARE RESOURCE UTILIZATION AND OUTCOMES IN PULMONARY ARTERIAL HYPERTENSION: EVIDENCE FROM A TERTIARY CENTER IN ARGENTINA
Aug 11, 2026, 17:16 PM -
SELECTION OF TREATMENT EFFECT MODIFIERS AND PROGNOSTIC FACTORS IN POPULATION-ADJUSTED INDIRECT COMPARISONS: A REVIEW AND IMPLICATIONS FOR DECISION-MAKING IN NICE
Aug 11, 2026, 17:16 PM -
CLINICAL AND ECONOMIC BURDEN OF GENERALIZED MYASTHENIA GRAVIS IN THE BRAZILIAN SUPPLEMENTARY HEALTHCARE SYSTEM: A REAL-WORLD STUDY (2019-2025)
Aug 11, 2026, 17:16 PM -
EVALUATING THE REAL-WORLD IMPACT OF UPDATED COLORECTAL CANCER SCREENING GUIDELINES IN THE UNITED STATES
Aug 11, 2026, 17:16 PM -
USE OF BIOSIMILARS IN FRENCH COMMUNITY PHARMACIES: A NATIONWIDE ANALYSIS USING OPEN-ACCESS MEDICO-ADMINISTRATIVE DATA (2016-2025)
Aug 11, 2026, 17:16 PM -
FROM PREDICTION TO POLICY: HEALTH TECHNOLOGY ASSESSMENT OF CLINICAL PREDICTION MODELS
Aug 11, 2026, 17:16 PM -
HUMANISTIC BURDEN OF NEUROFIBROMATOSIS TYPE 1 ON PATIENTS AND CAREGIVERS: A SYSTEMATIC LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS ANALYSES OF ANTIFIBROTICS FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS: A LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
HEALTH-RELATED QUALITY OF LIFE IN HEART FAILURE IN SAUDI ARABIA: A COMPARATIVE ASSESSMENT USING THE EQ-5D-5L AND EQ-HWB-9
Aug 11, 2026, 17:16 PM
